Profund Advisors LLC

SEC CIK: 0001129919
Latest filing: Aug 11, 2026

SEC filings (opens in a new tab)

ALNY holding history

Alnylam Pharmaceuticals, Inc. in every 13F filed by Profund Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALNY overview All 13F holders of ALNY Full Q2 2026 holdings

Shares (Q2 2026): 13,814
Value: $4.16M
% of portfolio: 0.1%
Quarters held: 22; Since Q1 2021

Holdings of ALNY by Profund Advisors LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	13,814	$4.16M	0.1%	−833−5.7%	Reduced	Holders
Q1 2026	14,647	$4.85M	0.2%	−942−6.0%	Reduced	Holders
Q4 2025	15,589	$6.20M	0.2%	+12,053+340.9%	Added	Holders
Q3 2025	3,536	$1.61M	0.1%	−2,882−44.9%	Reduced	Holders
Q2 2025	6,418	$2.09M	0.1%	−2,408−27.3%	Reduced	Holders
Q1 2025	8,826	$2.38M	0.1%	−869−9.0%	Reduced	Holders
Q4 2024	9,695	$2.28M	0.1%	−2,379−19.7%	Reduced	Holders
Q3 2024	12,074	$3.32M	0.1%	−2,328−16.2%	Reduced	Holders
Q2 2024	14,402	$3.50M	0.1%	+5,132+55.4%	Added	Holders
Q1 2024	9,270	$1.39M	0.1%	+938+11.3%	Added	Holders
Q4 2023	8,332	$1.59M	0.1%	+1,075+14.8%	Added	Holders
Q3 2023	7,257	$1.29M	0.1%	−472−6.1%	Reduced	Holders
Q2 2023	7,729	$1.47M	0.1%	+959+14.2%	Added	Holders
Q1 2023	6,770	$1.36M	0.1%	−6,954−50.7%	Reduced	Holders
Q4 2022	13,724	$3.26M	0.2%	+636+4.9%	Added	Holders
Q3 2022	13,088	$2.62M	0.2%	−717−5.2%	Reduced	Holders
Q2 2022	13,805	$2.01M	0.1%	−1,170−7.8%	Reduced	Holders
Q1 2022	14,975	$2.44M	0.1%	−1,471−8.9%	Reduced	Holders
Q4 2021	16,446	$2.79M	0.1%	−2,826−14.7%	Reduced	Holders
Q3 2021	19,272	$3.64M	0.1%	−789−3.9%	Reduced	Holders
Q2 2021	20,061	$3.40M	0.1%	−552−2.7%	Reduced	Holders
Q1 2021	20,613	$2.91M	0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.